肾移植后脑血流、神经化学物质及白质完整性恢复正常
本研究对29例ESKD患者和19例健康对照进行纵向脑MRI,评估肾移植前后脑血流、神经化学浓度及白质完整性的变化。结果显示移植前升高的脑血流及胆碱、肌醇浓度在移植后恢复正常,白质完整性指标FA升高、MD降低,提示部分脑异常可逆。
要点
- 肾移植可逆转ESKD相关的脑血流升高和神经化学异常。
- 移植后白质完整性改善,FA升高、MD降低。
- 需进一步研究机制及无法移植患者的干预措施。
核心结论
- CKD相关的某些脑异常是可逆的,并在肾移植后恢复正常。
研究设计与样本
- 研究纳入29例ESKD患者和19例年龄匹配健康对照,22例患者完成移植后MRI。
- 采用动脉自旋标记评估脑血流,磁共振波谱成像测量神经化学浓度,扩散张量成像评估白质完整性。
- 使用线性混合模型比较移植前、移植后3个月和12个月的纵向脑MRI测量值,并与健康对照比较。
主要发现
- 移植前患者脑血流高于对照(P=0.003),移植后下降(P<0.001)至对照水平。
- 移植前胆碱和肌醇浓度高于对照(P=0.001和P<0.001),移植后均恢复正常(P<0.001和P<0.001)。
- 移植后FA增加(P=0.001),MD降低(P<0.001)。
临床怎么用
- 肾移植可能改善ESKD患者的脑血流、神经化学及白质完整性异常。
- 对于ESKD患者,肾移植决策时可考虑其对脑部并发症的潜在益处。
局限性
- 样本量较小,22例患者完成移植后MRI。
- 需要进一步研究理解脑异常机制及探索无法移植患者的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CKD is associated with abnormalities in cerebral blood flow, cerebral neurochemical concentrations, and white matter integrity. Each of these is associated with adverse clinical consequences in the non-CKD population, which may explain the high prevalence of dementia and stroke in ESKD. Because cognition improves after kidney transplantation, comparing these brain abnormalities before and after kidney transplantation may identify potential reversibility in ESKD-associated brain abnormalities. METHODS: In this study of patients with ESKD and age-matched healthy controls, we used arterial spin labeling to assess the effects of kidney transplantation on cerebral blood flow and magnetic resonance spectroscopic imaging to measure cerebral neurochemical concentrations (N-acetylaspartate, choline, glutamate, glutamine, myo-inositol, and total creatine). We also assessed white matter integrity measured by fractional anisotropy (FA) and mean diffusivity (MD) with diffusion tensor imaging. We used a linear mixed model analysis to compare longitudinal, repeated brain magnetic resonance imaging measurements before, 3 months after, and 12 months after transplantation and compared these findings with those of healthy controls. RESULTS: Study participants included 29 patients with ESKD and 19 controls; 22 patients completed post-transplant magnetic resonance imaging. Cerebral blood flow, which was higher in patients pretransplant compared with controls (P=0.003), decreased post-transplant (P<0.001) to values in controls. Concentrations of neurochemicals choline and myo-inositol that were higher pretransplant compared with controls (P=0.001 and P<0.001, respectively) also normalized post-transplant (P<0.001 and P<0.001, respectively). FA increased (P=0.001) and MD decreased (P<0.001) post-transplant. CONCLUSIONS: Certain brain abnormalities in CKD are reversible and normalize with kidney transplantation. Further studies are needed to understand the mechanisms underlying these brain abnormalities and to explore interventions to mitigate them even in patients who cannot be transplanted. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Cognitive Impairment and Imaging Correlates in End Stage Renal Disease, NCT01883349.
引用
- Lepping RJ, Montgomery RN, Sharma P, et al. Normalization of Cerebral Blood Flow, Neurochemicals, and White Matter Integrity after Kidney Transplantation. J Am Soc Nephrol. 2020. PMID: 33067382. doi:10.1681/ASN.2020050584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。